The main focus of pre-clinical studies using DN-TNFs is on treatment of neurodegenerative diseases where elevated TNF levels are found at the site of injuries, such as MS, Parkinson’s disease (PD) and spinal cord injury (SCI). Here, TNF is linked to myeloid sarcoma.